- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Medical Marijuana Bill Heads to Pennsylvania Senate
Pennsylvania could soon pass a bill allowing the use of marijuana for medical purposes, the Cannabist reports. The bill passed the state House on Wednesday, and is now headed to the senate for approval.
Pennsylvania could soon pass a bill allowing the use of marijuana for medical purposes, the Cannabist reports. The bill passed the state House on Wednesday, and is now headed to the senate for approval.
As quoted in the publication:
The House voted 149-43 for legislation that would set standards for growers, dispensaries and physicians. Patients could take the drug in pill, oil or liquid form, but would not be able to obtain marijuana they could smoke.
Supporters said it would help relieve the suffering of sick people.
“Today we have the opportunity of offering hope to the parents of these children, to the patients, offering the hope of letting them, along with their doctors, decide how to best treat the conditions they’re dealing with on a daily basis,” said Rep. Jim Cox, R-Berks.
Opponents argued the Legislature should not be approving a drug that is illegal under federal law.
Click here for the full press release.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.